Status:
COMPLETED
Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder
Lead Sponsor:
National Institute of Mental Health (NIMH)
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the safety and effectiveness of two treatments to prevent relapses in seriously ill patients with major depressive disorder (MDD) who have responded to electroc...
Detailed Description
To define the role of continuation electroconvulsive therapy (C-ECT) in relapse-prevention of seriously ill patients with major depressive disorder (MDD). To determine the relative efficacy and safety...
Eligibility Criteria
Inclusion Criteria:
-
Patients must have:
Major depressive disorder that is responsive to acute phase ECT.
Key Trial Info
Start Date :
February 1 1997
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000375
Start Date
February 1 1997
Last Update
December 20 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New Jersey Medical School
Newark, New Jersey, United States, 07103